<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        35-325-01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RUMAFEN
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS</strong></p><p><strong>Cardiovascular Thrombotic Events</strong></p><p>o&nbsp;&nbsp;&nbsp; Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke ,which can be fatal. This risk may occur early in treatment and may increase with duration of use.</p><p>o&nbsp;&nbsp;&nbsp; Diclofenac Sodium delayed-release tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery</p><p><strong>Gastrointestinal Bleeding, Ulceration and perforation</strong></p><p>o&nbsp;&nbsp;&nbsp; NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events</p><p>&nbsp;</p><p>Diclofenac sodium, the active ingredient in RUMAFEN, is one of a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation. RUMAFEN tablets relieve pain, reduce swelling and ease inflammation in conditions affecting the joints, muscles and tendons including</p><p>(o&nbsp;&nbsp; Rheumatoid arthritis, osteoarthritis, acute gout (painful inflammation of the joints especially in the feet and hands), ankylosing spondylitis (form of spinal arthritis</p><p>o&nbsp;&nbsp; Backache, sprains and strains, soft tissue sports injuries, frozen shoulder, dislocations and fractures</p><p>o&nbsp;&nbsp; Conditions affecting the tendons for example, tendonitis, tenosynovitis, bursitis</p><p>They are also used to treat pain and inflammation associated with dental and minor surgery</p><p>In children aged 1-12 years RUMAFEN 25 mg tablets are used to treat juvenile chronic arthritis</p><p>In children aged 9 years and above RUMAFEN 25 mg tablets are used for short term treatment of fever related to infections of the ear, nose or throat, and for relief of acute post operative pain</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take RUMAFEN 25 mg Tablets if </strong></p><p>o&nbsp;&nbsp; you are allergic (hypersensitive) to diclofenac sodium, aspirin, ibuprofen or any other NSAID, or any of the other ingredients of RUMAFEN tablets (these are listed under section 6 &quot;FURTHER INFORMATION&quot; of the leaflet).Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems , runny nose , skin rash or any other allergic type reaction</p><p>(o&nbsp;&nbsp; you have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in faeces or black, tarry faeces</p><p>o&nbsp;&nbsp; you have had stomach or bowel problems after you have taken other NSAIDs</p><p>o&nbsp;&nbsp; &nbsp;you have severe heart, kidney or liver failure</p><p>o&nbsp;&nbsp; you have established heart disease and/or cerebrovascular disease, e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages</p><p>(o&nbsp;&nbsp; you have or have had problems with your blood circulation (peripheral arterial disease</p><p>o&nbsp;&nbsp; you are more than six months pregnant</p><p><strong>Warnings and precautions</strong></p><p><strong>Talk to your doctor or pharmacist before taking RUMAFEN 25 mg Tablets if</strong></p><p>o&nbsp;&nbsp; you suffer from any stomach or bowel disorders including ulcerative colitis or Crohn&rsquo;s disease</p><p>o&nbsp;&nbsp; you have kidney or liver problems, or you are elderly</p><p>o&nbsp;&nbsp; you have a condition called porphyria</p><p>o&nbsp;&nbsp; you suffer from any blood or bleeding disorder. If you do, your doctor may ask you to go for regular check-ups while you are taking these tablets</p><p>(o&nbsp;&nbsp; you ever had asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (nasal polyps</p><p>o&nbsp;&nbsp; chronic pulmonary diseases or infections of the respiratory tract</p><p>o&nbsp;&nbsp; you are breast feeding</p><p>o&nbsp;&nbsp; you have angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides</p><p>(o&nbsp;&nbsp; you have heart problems or if you had a stroke or you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes or high cholesterol or are a smoker</p><p>o&nbsp;&nbsp; you have diabetes</p><p>o&nbsp;&nbsp; you smoke</p><p>o&nbsp;&nbsp; you have Systemic Lupus Erythematosus SLE (inflammatory, auto-immune disorder which causes symptoms such as joint pain, joint inflammation, skin rashes, fever) or any similar condition</p><p>(o&nbsp;&nbsp; you have an intolerance to some sugars such as lactose (these tablets contain lactose</p><p><strong>Tell your doctor or pharmacist if you have any of these conditions because RUMAFEN 25 mg Tablets might not be the right medicine for you</strong></p><p><strong>Children</strong></p><p>In children aged 1-12 years RUMAFEN 25 mg tablets are used to treat juvenile chronic arthritis</p><p><strong>Other medicines and RUMAFEN 25 mg Tablets</strong></p><p>Some medicines can interfere with your treatment. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, especially any of the following</p><p>o&nbsp;&nbsp; Medicines to treat diabetes</p><p>(o&nbsp;&nbsp; Anticoagulants (blood thinning tablets like warfarin</p><p>(o&nbsp;&nbsp; Diuretics (water tablets</p><p>(o&nbsp;&nbsp; Lithium (used to treat some mental problems</p><p>(o&nbsp;&nbsp; Methotrexate (for treatment of some inflammatory diseases and some cancers</p><p>(o&nbsp;&nbsp; Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after transplants</p><p>(o&nbsp;&nbsp; Trimethoprim (a medicine used to prevent or treat urinary tract infections</p><p>(o&nbsp;&nbsp; Quinolone antibiotics (for infections</p><p>o&nbsp;&nbsp; Any other NSAID or COX-2 (cyclo-oxygenase-2) inhibitor, for example aspirin or ibuprofen</p><p>(o&nbsp;&nbsp; Mifepristone (a medicine used to terminate pregnancy</p><p>o&nbsp;&nbsp; Cardiac glycosides (for example digoxin), used to treat heart problems</p><p>(o&nbsp;&nbsp; Medicines known as SSRIs (used to treat depression</p><p>(o&nbsp;&nbsp; Oral steroids (an anti-inflammatory drug</p><p>o&nbsp;&nbsp; Medicines used to treat heart conditions or high blood pressure, for example beta blockers or ACE inhibitors</p><p>(o&nbsp;&nbsp; Voriconazole (a medicine used to treat fungal infections</p><p>(o&nbsp;&nbsp; Phenytoin (a medicine used to treat seizures</p><p>(o&nbsp;&nbsp; Colestipol/cholestyramine (used to lower cholesterol</p><p>Always tell your doctor or pharmacist about all the medicines you are taking. This means medicines you have bought yourself as well as medicines on prescription from your doctor</p><p><strong>Taking RUMAFEN 25 mg Tablets with food and drink</strong></p><p>Take this medicine with or after food</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Although not common, abnormalities have been reported in babies whose mothers have taken NSAIDs during pregnancy. You should not take RUMAFEN 25 mg tablets during the last 3 months of pregnancy as it may affect the baby&#39;s circulation</p><p>o&nbsp;&nbsp; You should advise your doctor or pharmacist if you think you might be pregnant or up to 6 months pregnant</p><p>o&nbsp;&nbsp; Taking RUMAFEN tablets may make it more difficult to become pregnant. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant</p><p>o&nbsp;&nbsp; You should avoid taking RUMAFEN whilst breast feeding</p><p><strong>Driving and using machines</strong></p><p>Very occasionally people have reported that diclofenac sodium tablets have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery</p><p><strong>Other special warnings</strong></p><p>o&nbsp;&nbsp; You should take the lowest effective dose of Diclofenac Sodium for the shortest possible time particularly if you are underweight or elderly</p><p>o&nbsp;&nbsp; There is a small increased risk of heart attack or stroke when you are taking any medicine like Diclofenac Sodium. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for</p><p>o&nbsp;&nbsp; Whilst you are taking these medicines your doctor may want to give you a check-up from time to time</p><p>o&nbsp;&nbsp; If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms</p><p>o&nbsp;&nbsp; Because it is an anti-inflammatory medicine, Diclofenac Sodium tablets may reduce the symptoms of infection, for example, headache, and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking RUMAFEN tablets</p><p><strong>RUMAFEN 25 mg Tablets contains</strong></p><p>RUMAFEN 25 mg Tablets contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor will tell you how many RUMAFEN 25 mg tablets to take and when to take them. Always take RUMAFEN exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Keep taking your tablets for as long as you have been told, unless you have any problems. In that case, check with your doctor. Take the tables with or after food. Swallow the tablets whole with a glass of water. <strong>DO NOT </strong>crush or chew the tablets</p><p>&nbsp;</p><p>The usual dose is</p><p><strong>Adults and children over 12 years old</strong></p><p>75 to 150 mg daily in two or three divided doses</p><p>The number of tablets which you take will depend on the strength the doctor has given you.</p><p><strong>Elderly</strong></p><p>The lowest effective dose should be used. Your doctor may advise you to take a dose that is lower than the usual adult dose if you are elderly. Your doctor may also want to check closely that the Diclofenac Sodium tablets are not affecting your stomach</p><p><strong>Children aged 1 to 12 years</strong></p><p>Doses vary with the age and weight of the child. These tablets may be given to children but not to infants, where applicable, within the daily dose range of 1-3 mg per kilogram of body weight in two or three separate doses</p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, or if you are elderly, or taking certain other drugs as well</p><p><strong>If you take more RUMAFEN 25 mg Tablets than you should </strong></p><p>If you, or anyone else, accidentally takes too much RUMAFEN, tell your doctor or go to your nearest<strong> </strong>hospital casualty department immediately. Take your medicine pack with you so that people can see<strong> </strong>what you have taken</p><p>Symptoms of an overdose can include: headache, nausea (feeling sick), vomiting, abdominal pain,<strong> </strong>stomach or intestinal bleeding, rarely diarrhea, disorientation, excitation, coma, drowsiness,<strong> </strong>dizziness, ringing in the ears, fainting, or occasionally convulsions (seizures, uncontrolled fits&nbsp;</p><p><strong>If you forget to take RUMAFEN</strong></p><p>It is important that you do not miss a dose. If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, just take the next dose and forget about the one you missed. Do NOT take a double dose to make up for a forgotten tablet. Do not take more than 150 mg in 24 hours. If you have trouble remembering to take the tablets, tell your doctor or pharmacist. If you have any further questions on the use of this product, ask your doctor or pharmacist</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, RUMAFEN can cause side effects, although not everybody gets them</p><p><u><strong>Some side effects can be serious</strong></u></p><p><strong>STOP TAKING RUMAFEN 25 mg Tablets and seek immediate medical help if you notice</strong></p><p>(o&nbsp;&nbsp; Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick</p><p>o&nbsp;&nbsp; Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels</p><p>o&nbsp;&nbsp; blood in vomit or black, tarry faeces</p><p>o&nbsp;&nbsp; Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or Blistering</p><p>(o&nbsp;&nbsp; Wheezing or shortness of breath (bronchospasm</p><p>o&nbsp;&nbsp; Swollen face, lips, hands or fingers</p><p>o&nbsp;&nbsp; Yellowing of your skin or the whites of your eyes</p><p>o&nbsp;&nbsp; Persistent sore throat or high temperature</p><p>o&nbsp;&nbsp; An unexpected change in the amount of urine produced and/or its appearance</p><p>o&nbsp;&nbsp; Mild cramping and tenderness of the abdomen, starting shortly after the start of the treatment with Diclofenac Sodium and followed by rectal bleeding or bloody diarrhea usually within 24 hours of the onset of abdominal pain</p><p>(o&nbsp;&nbsp; Stevens Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals</p><p>If you notice that you are bruising more easily than usual or have frequent sore throats or infections, tell your doctor</p><p><strong>The side effects listed below have also been reported</strong></p><p><strong><u>Common (may affect up to 1 in 10 people)</u></strong></p><p>o&nbsp;&nbsp; Stomach pain, heartburn, nausea, vomiting, diarrhea, indigestion, wind, loss of appetite</p><p>o&nbsp;&nbsp; Headache, dizziness, vertigo</p><p>o&nbsp;&nbsp; Skin rash or spots</p><p>o&nbsp;&nbsp; Raised levels of liver enzymes in the blood</p><p><strong><u>Rare (may affect up to 1 in 1,000 people)</u></strong></p><p>(o&nbsp;&nbsp; Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly</p><p>(o&nbsp;&nbsp; Gastritis (inflammation, irritation or swelling of the stomach lining</p><p>o&nbsp;&nbsp; Vomiting blood</p><p>o&nbsp;&nbsp; Diarrhoea with blood in it or bleeding from the back passage</p><p>o&nbsp;&nbsp; Black, tarry faeces or stools</p><p>o&nbsp;&nbsp; Drowsiness, tiredness</p><p>(o&nbsp;&nbsp; Hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness</p><p>o&nbsp;&nbsp; Skin rash and itching</p><p>o&nbsp;&nbsp; Fluid retention, symptoms of which include swollen ankles</p><p>o&nbsp;&nbsp; Liver function disorders, including hepatitis and jaundice</p><p><strong><u>(Very rare (may affect up to 1 in 10,000 people</u></strong></p><p><strong>Effects on the nervous system</strong></p><p>Tingling or numbness in the fingers, tremor, blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, mental disorders, disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck, disturbances in sensation</p><p><strong>Effects on the stomach and digestive system </strong></p><p>(Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the mouth or<strong> </strong>lips, taste changes, lower gut disorders (including of the colon or worsening of ulcerative colitis or<strong> </strong>Crohn&rsquo;s disease</p><p><strong>Effects on the heart, chest or blood</strong></p><p>Palpitations (fast or irregular heart beat), chest pain, hypertension (high blood pressure), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), heart disorders, including congestive heart failure or heart attack, blood disorders (including (anaemia</p><p><strong>Effects on the liver or kidneys</strong></p><p>Kidney or severe liver disorders including liver failure, presence of blood or protein in the urine</p><p><strong>Effects on skin or hair</strong></p><p>Serious skin rashes including Stevens-Johnson syndrome, Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight. Hair loss</p><p><strong>Other side effects that have also been reported include</strong></p><p>Inflammation of the pancreas, impotence. Facial swelling, inflammation of the lining of the brain (meningitis), stroke, throat disorders, confusion, hallucinations, malaise (general feeling of discomfort), inflammation of the nerves in the eye</p><p><strong>Do not be alarmed by this list - most people take Diclofenac Sodium Tablets without any problems&nbsp;</strong></p><p><strong>If any of the side effects becomes serious, or if you notice side effects not listed in this leaflet, please tell your doctor or the pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>o&nbsp;&nbsp; Keep out of the sight and reach of children</p><p>o&nbsp;&nbsp; Store in original package in order to protect from light</p><p>o&nbsp;&nbsp; Store below 30 &deg;C</p><p>o&nbsp;&nbsp; Do not use RUMAFEN Tablets after the expiry date printed on the pack. The expiry date refers to the last day of that month</p><p>o&nbsp;&nbsp; Do not throw any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environmen</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each Enteric Coated tablet contains Diclofenac Sodium (BP) 25 mg</p><p><strong>(Other ingredients: </strong>Microcryst Cellulose (PH101), Lactose, Maize Starch, Povidone (K30), Magnesium Stearate and enteric coating materials (Eudragit L30D-55, Triethyl Citrate, Titanium Dioxide and Purified Talc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Each Enteric Coated tablet looks White to off white , enteric coated , biconvex, circular tablets with RP engraved on one side and 7 on the other side
Packs contain (20) Enteric Coated tablets of RUMAFEN 25 mg
10’s Blister of transparent PVC-PVDC film / Aluminium foil

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>(Medical and Cosmetic Products Company Ltd. (Riyadh Pharma</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p><em>For any information about this medicinal product, please contact the local representative of marketing authorization holder</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised (5/2018)
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p><strong>مخاطر</strong><strong> </strong><strong>الحوادث</strong><strong> </strong><strong>القلبية</strong><strong> </strong><strong>الوعائية</strong><strong> </strong><strong>و</strong><strong> </strong><strong>الجهاز</strong><strong> </strong><strong>الهضمي</strong><strong> </strong><strong>الخطيرة</strong><strong>:</strong></p><p><strong>مخاطر</strong><strong> </strong><strong>الجلطة</strong><strong> </strong><strong>القلبية</strong><strong> </strong><strong>الوعائية</strong></p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسبب العقاقير المضادة للالتهاب غير الستيرويدية(NSAIDs) &nbsp;زيادة في خطر الإصابة بالأعراض الخطيرة لأمراض القلب والأوعية الدموية ، بما في ذلك احتشاء عضلة القلب والسكتة الدماغية ، والتي يمكن أن تكون قاتلة. قد تحدث هذه المخاطر في وقت مبكر من العلاج وقد تزيد مع مدة الاستخدام.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمنع استخدام أقراص ديكلوفيناك الصوديوم ذات التأثير المؤخر في عملية ضبط الشريان التاجي .(CABG)</p><p><strong>نزيف</strong><strong> </strong><strong>الجهاز</strong><strong> </strong><strong>الهضمي</strong><strong> </strong><strong>،</strong><strong> </strong><strong>التقرح</strong><strong> </strong><strong>والانثقاب</strong></p><p>تسبب مضادات الالتهاب غير الستيرويدية خطرًا متزايدًا لأعراض الجهاز الهضم &nbsp;الخطيرة(GI)&nbsp; &nbsp;بما في ذلك النزيف والتقرح وانثقاب المعدة أو الأمعاء ، والتي يمكن أن تكون قاتلة. يمكن أن تحدث هذه الأحداث في أي وقت أثناء الاستخدام ودون أعراض تحذيرية. المرضى المسنون والمرضى الذين لديهم تاريخ سابق لمرض القرحة الهضمية و / أو نزيف الجهاز الهضمي يكونون أكثر عرضة لأحداث خطيرة في الجهاز الهضمي.</p><p>&nbsp;</p><p>ديكلوفيناك الصوديوم، هو المادة الفعالة في رومافن، وهو واحد من مجموعة من الأدوية تسمى العقاقير غير الستيرويدية المضادة للالتهابات (المسكنات(.</p><p>المسكنات تقلل من الألم والالتهاب. أقراص رومافن تخفف الألم، تقلل التورم وتخفف الالتهاب في الحالات التي تؤثر على المفاصل والعضلات و الأوتار وتشمل:</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المفاصل الروماتويدي والتهاب المفاصل والنقرس الحاد )التهاب مؤلم في المفاصل وخاصة في القدمين واليدين( التهاب الفقار اللاصق &nbsp;)شكل من أشكال التهاب المفاصل في العمود الفقري)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الظهر، والالتواء والسلالات، والإصابات الرياضية في الأنسجة اللينة، الكتف المتجمدة، الخلع والكسور.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحالات التي تؤثر على الأوتار على سبيل المثال، التهاب الأوتار، التهاب غمد الوتر، الالتهاب الكيسي. كما أنه يستخدم لعاج الألم والالتهابات المرتبطة بجراحة الأسنان والجراحات البسيطة.</p><p>في الأطفال الذين تتراوح أعمارهم بين 1-12 سنة &nbsp;يستخدم رومافن 25 ملجم لعلاج التهاب المفاصل المزمن للاطفال.</p><p>في الأطفال الذين تتراوح أعمارهم بين 9 سنوات وما فوق يستخدم رومافن 25 ملجم للعلاج على المدى القصير في الحمى المتعلقة بالتهابات الأذن والأنف أو الحلق، ولتخفيف الآلام الحادة بعد العمليات الجراحية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>رومافن</strong><strong> 25 </strong><strong>ملجم</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>إذا</strong><strong>:</strong></p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك حساسية (الحساسية( &nbsp;لديكلوفيناك الصوديوم، والأسبرين والايبوبروفين أو أي من المسكنات الأخرى، أو أي من المكونات الأخرى للأقراص رومافن ) المدرجة في القسم 6 &quot;معلومات إضافية&quot; من هذه النشرة)&nbsp;. علامات تفاعل فرط الحساسية تشمل تورم الوجه والفم (الوذمة الوعائية) ، ومشاكل في التنفس ، و رشح الأنف ، والطفح الجلدي أو أي نوع آخر من الحساسية.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك الآن ، أو كان لديك في أي وقت مضى ، قرحة المعدة أو قرحة الاثني عشر، أو نزيف في الجهاز الهضمي &nbsp;وهذا يمكن أن يشمل دم في القيء ، ونزيف عند إفراغ الأمعاء، و دم جديد في البراز أو براز أسود (بلون القطران)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشاكل في المعدة أو الأمعاء بعد تناول مضادات الالتهاب غير الستيرويدية الأخرى.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك قصور شديد في القلب أو الكلى أو الكبد</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك أمراض القلب و / أو الأمراض القلبية الوعائية ، على سبيل المثال ، إذا كنت تعاني من نوبة قلبية أو سكتة دماغية أو ضربة دماغية (TIA) أو انسداد في الأوعية الدموية إلى القلب أو المخ أو أجريت عملية لإزالة أو تخطي الانسداد.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك أو كان لديك مشاكل في الدورة الدموية &nbsp;(مرض الشرايين الطرفية)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنتي حامل لأكثر من ستة أشهر</p><p><strong>الاحتياطات</strong><strong> </strong><strong>و</strong><strong> </strong><strong>التحذيرات</strong></p><p><strong>تحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>او</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>قبل</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>رومافن</strong><strong> </strong><strong>25 ملجم</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>اذا</strong><strong>:</strong></p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من أي اضطرابات في المعدة أو الأمعاء بما في ذلك التهاب القولون التقرحي أو داء كرون</p><p>كان لديك مشاكل في الكلى أو الكبد ، أو كنت من كبار السن</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك حالة تسمى البورفيريا</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من أي اضطراب دموي أو نزيف. إذا قمت بذلك ، قد يطلب منك الطبيب إجراء فحوصات منتظمة أثناء تناول هذه الأقراص.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سبق وأن أصبت بالربو ، التهاب الأنف التحسسي الموسمي ، تورم في الغشاء المخاطي للأنف )أورام الأنف(، أمراض رئوية مزمنة أو عدوى في الجهاز التنفسي.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنتي ترضعين طفلك رضاعة طبيعية</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من الذبحة الصدرية ، أو جلطات الدم ، أو ارتفاع ضغط الدم ، أو زيادة الكولسترول أو ارتفاع مستوى الدهون الثلاثية</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مشاكل في القلب أو إذا كنت تعاني من سكتة دماغية أو تعتقد أنك معرض لخطر هذه الحالات (على سبيل المثال ، إذا كنت تعاني من ارتفاع ضغط الدم أو مرض السكري أو ارتفاع نسبة الكوليسترول أو كنت مدخنًا(</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مرض السكري</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تدخن</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مرض الذئبة الحمامية الجهازية &nbsp;SLE (الاضطراب الالتهابي التلقائي المناعي الذي يسبب أعراض مثل آلام المفاصل ، التهاب المفاصل ، الطفح الجلدي ، الحمى ( أو أي حالة مشابهة</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك عدم تحمل بعض السكريات مثل اللاكتوز (تحتوي هذه الأقراص على اللاكتوز(</p><p><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>هذه الحالات</strong><strong> </strong><strong>لأن</strong><strong> </strong><strong>رومافن</strong><strong> 25 </strong><strong>ملجم</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>لا</strong><strong> </strong><strong>يكون الدواء</strong><strong> </strong><strong>المناسب</strong><strong> </strong><strong>لك</strong><strong>.</strong></p><p><strong>الأطفال</strong></p><p><strong>في</strong><strong> </strong><strong>الأطفال</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>تتراوح</strong><strong> </strong><strong>أعمارهم</strong><strong> </strong><strong>بين1-12 سنة يستخدم</strong><strong> </strong><strong>رومافن</strong><strong> 25 </strong><strong>ملجم</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>لعلاج</strong><strong> </strong><strong>التهاب المفاصل</strong><strong> </strong><strong>المزمن</strong><strong> </strong><strong>للأطفال</strong><strong>.</strong></p><p><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>و</strong><strong> </strong><strong>رومافن</strong></p><p>يمكن لبعض الأدوية ان تتداخل مع العلاج. يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية، وخاصة أي مما يلي:</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج مرض السكري</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات التخثر (أقراص ترقق الدم مثل الوارفارين)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدرات البول &nbsp;(أقراص الماء)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الليثيوم (يستخدم لعلاج بعض المشاكل العقلية)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميثوتريكسات &nbsp;(لعلاج بعض الأمراض الالتهابية وبعض أنواع السرطان)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيكلوسبورين و تاكروليماس (يستخدمان لعاج بعض الأمراض الالتهابية وبعد زراعة الأعضاء)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تريميثوبريم&nbsp; (دواء يستخدم لمنع أو عاج عدوى المسالك البولية)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المضادات الحيوية الكينولون &nbsp;(للعدوى)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي NSAID أو مثبطات COX-2 &nbsp;&nbsp;(سيكلو أوكسجيناز-2) ، على سبيل المثال الأسبرين أو الأيبوبروفين.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميفيبريستون (دواء يستخدم لإنهاء الحمل).</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جليكوسيدات قلبية &nbsp;(على سبيل المثال الديجوكسين) ، تستخدم لعلاج مشاكل القلب.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المعروفة باسم SSRIs (المستخدمة لعلاج الاكتئاب).</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الستيرويدات عن طريق الفم &nbsp;)دواء مضاد للالتهابات)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج أمراض القلب أو ارتفاع ضغط الدم ، مثل حاصرات بيتا أو مثبطات الإنزيم المحول للأنجيوتنسين</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فوريكونازول )دواء يستخدم لعلاج الالتهابات الفطرية)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفينيتوين &nbsp;(دواء يستخدم لعلاج النوبات)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كولستيبول / كوليسترامين (يستخدم لخفض الكولسترول)</p><p>دائما أخبر طبيبك أو الصيدلي عن جميع الأدوية التي تتناولها. هذا يعني الأدوية التي قد اشتريتها بنفسك وكذلك الأدوية على وصفة طبية من طبيبك.</p><p><strong>تناول</strong><strong> </strong><strong>رومافن</strong><strong> 25 </strong><strong>ملجم</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>الطعام</strong><strong> </strong><strong>والشراب</strong></p><p>تناول هذا الدواء مع أو بعد الطعام.</p><p><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong><strong> </strong><strong>الطبيعية</strong></p><p>على الرغم من أنها ليست شائعة، تم الإبلاغ عن تشوهات في المواليد الذين تناولت امهاتهم المسكنات أثناء الحمل. يجب عدم تناول أقراص رومافن خلال3 أشهر الأخيرة من الحمل لأنها قد تؤثر على الدورة الدموية للطفل.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي أن تستشيري طبيبك أو الصيدلي إذا كنت حامل أو تعتقدين أنك قد تكونين حاملا.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول أقراص رومافن قد يجعل الأمر أكثر صعوبة لتصبحي حاملا. يجب عليك التحدث مع طبيبك إذا كنت تخططين لتصبحي حاما، أو إذا كان لديك مشاكل في الحصول على الحمل.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب تجنب تناول رومافن مع الرضاعة الطبيعية.</p><p><strong>استخدام</strong><strong> </strong><strong>الآلات</strong><strong> </strong><strong>و</strong><strong> </strong><strong>القيادة</strong></p><p>في كثير من الأحيان ابلغ الناس أن أقراص ديكلوفيناك الصوديوم تجعلهم يشعرون بالدوار أو التعب أو النعاس. كما تم الإبلاغ عن مشاكل في البصر. إذا تأثرت بهذه الطريقة، يجب أن لا تقوم بقيادة السيارة أو تقوم بتشغيل الآلات.</p><p><strong>تحذيرات</strong><strong> </strong><strong>خاصة</strong><strong> </strong><strong>أخرى</strong></p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب أن تتناول أقل جرعة فعالة من ديكلوفيناك الصوديوم لأقصر فترة زمنية ممكنة خاصة إذا كنت ناقص الوزن أومن كبار السن.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هناك زيادة صغيرة في خطر الإصابة بنوبة قلبية أو سكتة دماغية عند تناول أي دواء مثل ديكلوفيناك الصوديوم. الخطر أعلى إذا كنت تتناول جرعات عالية لفترة طويلة. اتبع دائمًا إرشادات الطبيب حول مقدار ما يجب تناوله وطول مدة تناوله.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الوقت الذي تتناول فيه هذه الأدوية ، قد يرغب طبيبك في عمل فحص لك من وقت لآخر.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تاريخ من مشاكل المعدة عند تناول مضادات الالتهاب غير الستيرويدية ، خاصة إذا كنت مسناً ، يجب أن تخبر طبيبك فوراً إذا لاحظت أي أعراض غير عادية.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نظرًا لأنه دواء مضاد للالتهابات ، فقد تقلل أقراص ديكلوفيناك الصوديوم من أعراض العدوى ، على سبيل المثال ، الصداع ، وارتفاع درجة الحرارة. إذا شعرت بتوعك واحتجت لرؤية طبيب ، تذكر أن تخبره بأنك تتناول أقراص ديكلوفيناك الصوديوم.</p><p><strong>يحتوي</strong><strong> </strong><strong>رومافن</strong><strong> 25 </strong><strong>ملجم</strong><strong> </strong><strong>أقراص</strong></p><p>يحتوي رومافن 25 ملجم أقراص على اللاكتوز. إذا أخبرك طبيبك بأن لديك عدم قدرة على تحمل بعض السكريات ، اتصل بطبيبك قبل تناول هذا المنتج الطبي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سوف يخبرك الطبيب كم قرص رومافن يجب أن تتناول و اوقات تناولهم. تناول رومافن دائما تماما كما اخبرك الطبيب. يجب عليك التحقق من طبيبك أو الصيدلي إذا لم تكن متأكدا. استمر في تناول الاقراص</p><p>كيفما قيل لك، إلا إذا كان لديك أي مشاكل. في هذه الحالة، يجب مراجعة الطبيب. تناول الأقراص مع أو بعد الطعام.</p><p>ابتلع الأقراص كاملة مع كوب من الماء. لا تسحق أو تمضغ الأقراص.</p><p>الجرعة المعتادة هي:</p><p><strong>البالغين</strong><strong> </strong><strong>و</strong><strong> </strong><strong>الأطفال</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>تجاوزوا</strong><strong> 12 </strong><strong>سنة</strong><strong>:</strong></p><p>75-150 ملجم يوميا مقسمة الى 2 او 3 جرعات. &nbsp;يعتمد عدد الأقراص التي تتناولها على التركيز الذي وصفه لك الطبيب.</p><p><strong>كبار</strong><strong> </strong><strong>السن</strong><strong>:</strong></p><p>يجب استخدام أقل جرعة فعالة. قد ينصح الطبيب لك أن تتناول جرعة أقل من جرعة الكبار وهذا هو المعتاد إذا كنت من كبار السن. قد يرغب طبيبك أيضًا في التحقق من أن أقراص ديكلوفيناك الصوديوم لا تؤثر على معدتك .</p><p><strong>الأطفال</strong><strong>:</strong></p><p>الأطفال الذين تتراوح أعمارهم بين1-12 سنة:</p><p>الجرعات تختلف مع عمر ووزن الطفل. يمكن إعطاء 25 ملجم للأطفال ولكن ليس للرضع، عند الحاجة، &nbsp;ضمن نطاق الجرعة اليومية من 1-3 ملجم لكل كيلوجرام من وزن الجسم على جرعتين أو ثلاثة جرعات مقسمة.</p><p>قد يصف الطبيب أيضًا دواء آخر في الوقت نفسه لحماية المعدة ، خاصة إذا كنت تعاني من مشاكل في المعدة من قبل ، أو إذا كنت مسناً ، أو إذا كنت تتناول أدوية أخرى .</p><p><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>رومافن</strong><strong> 25 </strong><strong>ملجم</strong><strong> </strong><strong>أقراص</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p>إذا كنت، أو أي شخص آخر، تناول عن طريق الخطأ كثير من رومافن، أخبر طبيبك أو اذهب إلى أقرب قسم طوارئ على الفور. اصطحب علبة الدواء معك حتى يتمكن الاطباء من معرفة ما تناولت.</p><p>أعراض الجرعة الزائدة يمكن أن تشمل: صداع، غثيان (الشعور المرضي) ، التقيؤ، آلام في البطن والمعدة أو نزيف في الامعاء، ونادرا الإسهال، والارتباك، والإثارة، والغيبوبة، والنعاس، والدوخة، وطنين في الأذنين، والاغماء، أو في بعض الأحيان التشنجات (النوبات)</p><p><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>رومافن</strong></p><p>من المهم أن لا تنسى الجرعة . إذا نسيت تناول جرعة، تناول الجرعة بمجرد التذكر. إذا اقترب وقت تناول الجرعة التالية، فقط تناول الجرعة القادمة وتغاضي عن الجرعة التي فاتتك. لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية. لا تتناول أكثر من 150 ملجم خلال 24 ساعة. إذا كان لديك صعوبة في تذكر تناول الاقراص، أخبر طبيبك أو الصيدلي.</p><p><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أسئلة</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>حول</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>هذا الدواء</strong><strong> </strong><strong>،</strong><strong> </strong><strong>اسأل</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يتسبب رومافن في آثار جانبية، على الرغم من ذلك فأنها لا تحدث للجميع.</p><p><strong>بعض</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>يمكن</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تكون</strong><strong> </strong><strong>خطيرة توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>رومافن</strong><strong> </strong><strong>واطلب</strong><strong> </strong><strong>المساعدة</strong><strong> </strong><strong>الطبية الفورية</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت</strong><strong>:</strong></p><p>&bull;ألم المعدة ، وعسر الهضم ، وحرقة المعدة ، والرياح ، والغثيان (الشعور بالمرض) &nbsp;أو القيء &nbsp;(المرض)</p><p>&bull;أي علامة نزيف في المعدة أو الأمعاء ، على سبيل المثال ، عند إفراغ أمعائك دم بالقيء أو براز أسود بلون القطران</p><p>&bull;ردود الفعل التحسسية التي يمكن أن تشمل الطفح الجلدي ، الحكة ، الكدمات ، مناطق حمراء مؤلمة ، التقشير أو تقرحات</p><p>&bull;صفير أو ضيق في التنفس )تشنج قصبي)</p><p>&bull;ﺗورم الوجه أو اﻟشفاة &nbsp;أو اﻟيدﻳن أو الأصابع</p><p>&bull;اصفرار بشرتك أو بياض عينيك</p><p>&bull;استمرار التهاب الحلق أو ارتفاع درجة الحرارة</p><p>&bull;تغيير غير متوقع في كمية البول و / أو مظهره.</p><p>&bull;التشنج الخفيف و ألم في البطن ، تبدأ بعد وقت قصير من بدء العلاج مع ديكلوفيناك الصوديوم ويتبعه نزف مستقيمي أو إسهال دموي عادة خلال 24 ساعة من بداية الألم البطني.</p><p>&bull;متلازمة ستيفنز جونسون &nbsp;(مرض خطير مع تقرحات في الجلد والفم والعينين والأعضاء التناسلية)</p><p>إذا لاحظت أنك تتعرض لكدمات أكثر سهولة من المعتاد أو لديك التهاب الحلق أو الالتهابات المتكررة ، أخبر طبيبك.</p><p><strong>تم</strong><strong> </strong><strong>الإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>المذكورة</strong><strong> </strong><strong>أدناه</strong><strong>.</strong></p><p><u><strong>شائعة</strong><strong> </strong><strong>&nbsp;(قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>واحد</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل </strong><strong>&nbsp;10</strong><strong> أشخاص):</strong></u></p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم المعدة وحرقة المعدة والغثيان والقيء والإسهال وعسر الهضم والريح وفقدان الشهية</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع ، دوار ، دوخة</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أو بقع</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات مرتفعة من إنزيمات الكبد في الدم</p><p><u><strong>نادرة</strong><strong> </strong><strong>&nbsp;(قد</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>واحد</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> 1000</strong><strong> شخص</strong><strong> </strong><strong>):</strong></u></p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرحة في المعدة أو نزيف &nbsp;)كانت هناك حالات نادرة جداً تم الإباغ عنها أدت إلى الوفاة ، خاصة عند كبار السن)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المعدة (التهاب أو تهيج أو انتفاخ في بطانة المعدة)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قيء دموي</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال دموي أو نزيف من المستقيم</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; براز أسود أو براز بلون القطران</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النعاس والإرهاق</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم (انخفاض ضغط الدم ، قد تشمل أعراضه الضعف أو الدوخة أو الدوار الخفيف)</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي وحكة</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس السوائل ، تشمل أعراضه كواحل منتفخة</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات وظائف الكبد ، بما في ذلك التهاب الكبد واليرقان</p><p><strong><u>نادرة</u></strong><strong><u> </u></strong><strong><u>جدًا</u></strong><strong><u> (</u></strong><strong><u>قد</u></strong><strong><u> </u></strong><strong><u>تؤثر</u></strong><strong><u> </u></strong><strong><u>على</u></strong><strong><u> </u></strong><strong><u>شخص</u></strong><strong><u> </u></strong><strong><u>واحد</u></strong><strong><u> </u></strong><strong><u>من</u></strong><strong><u> </u></strong><strong><u>كل 1000</u></strong><strong><u> </u></strong><strong><u>شخص</u></strong><strong><u>)</u></strong><strong><u>:</u></strong></p><p><em>آثار على الجهاز العصبي:</em></p><p>وخز أو خدر في الأصابع أو الرعشة أو عدم وضوح الرؤية أو ضعف الرؤية أو فقدان السمع أو ضعف السمع أو طنين الأذن &nbsp;)الرنين في الأذنين( أو الأرق أو الكوابيس أو تغيرات المزاج أو الاكتئاب أو القلق أو الاضطرابات النفسية أو الارتباك وفقدان الذاكرة أو النوبات أو الصداع جنبا إلى جنب مع كراهية الأضواء الساطعة والحمى وتيبس الرقبة واضطرابات في الإحساس.</p><p><em>آثار</em><em> </em><em>على</em><em> </em><em>المعدة</em><em> </em><em>والجهاز</em><em> </em><em>الهضمي</em><em>:</em></p><p>الإمساك ، التهاب اللسان ، قرحة الفم ، التهاب داخل الفم أو الشفتين ، تغيرات الذوق ، اضطرابات الأمعاء السفلى (بما في ذلك القولون أو تفاقم التهاب القولون التقرحي أو مرض كرون)</p><p><em>آثار</em><em> </em><em>على</em><em> </em><em>القلب</em><em> </em><em>أو</em><em> </em><em>الصدر</em><em> </em><em>أو</em><em> </em><em>الدم</em><em>:</em></p><p>خفقان &nbsp;)ضربات سريعة أو عدم انتظام ضربات القلب( ، ألم في الصدر ، ارتفاع ضغط الدم ، التهاب الأوعية الدموية ، التهاب في الرئة ، اضطرابات في القلب ، بما في ذلك قصور القلب الاحتقاني أو نوبة قلبية واضطرابات الدم )بما في ذلك فقر دم)</p><p><em>آثار</em><em> </em><em>على</em><em> </em><em>الكبد</em><em> </em><em>أو</em><em> </em><em>الكليتين</em><em>:</em></p><p>أمراض الكلى أو الكبد الحاد بما في ذلك فشل الكبد أو وجود الدم أو البروتين في البول</p><p><em>آثار</em><em> </em><em>على</em><em> </em><em>الجلد</em><em> </em><em>أو</em><em> </em><em>الشعر</em><em>:</em></p><p>طفح جلدي خطير بما في ذلك متلازمة ستيفنز جونسون ومتلازمة ليل وطفح جلدي آخر الذي قد يصبح أسوأ بسبب التعرض لأشعة الشمس.</p><p>تساقط الشعر.</p><p><strong>تشمل</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>تم</strong><strong> </strong><strong>الإبلاغ</strong><strong> </strong><strong>عنها أيضًا</strong><strong>:</strong></p><p>التهاب البنكرياس والعجز الجنسي. تورم الوجه ، التهاب بطانة الدماغ &nbsp;(التهاب السحايا(، والسكتة الدماغية ، واضطرابات الحلق ، والارتباك ، والهلوسة ، والشعور بالضيق (الشعور العام بالانزعاج) ، والتهاب الأعصاب في العين.</p><p><strong>لا</strong><strong> </strong><strong>تقلق</strong><strong> </strong><strong>من</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>القائمة</strong><strong> - </strong><strong>معظم</strong><strong> </strong><strong>الناس</strong><strong> </strong><strong>يتناولون أقراص</strong><strong> </strong><strong>ديكلوفيناك</strong><strong> </strong><strong>الصوديوم</strong><strong> </strong><strong>دون</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>مشاكل</strong><strong>.</strong></p><p><strong>إذا</strong><strong> </strong><strong>اصبح</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>خطيرا،</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لاحظت آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>المذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة،</strong><strong> </strong><strong>يرجى إخبار</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>بذلك</strong><strong>. </strong><strong>فانه</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>يريد</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>يقدم</strong><strong> </strong><strong>لكم</strong><strong> </strong><strong>دواء مختلف</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في العبوة الأصلية للحماية من الضوء.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم استعمال رومافن 25 ملجم أقراص بعد تاريخ انتهاء الصلاحية المذكور على العبوة. تاريخ الانتهاء يشير الى اخر يوم في ذلك الشهر.</p><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التخلص من الأدوية يجب ألا يكون عن طريق مياه الصرف الصحي أو النفايات المنزليه. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبه. هذه التدابير مساعده في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي كل قرص مغلف تغليفا معويا على ديكلوفيناك الصوديوم (دستور الأدوية البريطاني) &nbsp;25 ملجم.</p><p>المواد الإضافية: مايكروكريست سيليلوز PH 10، لاكتوز، نشا ذرة، بوفيدون k30 ، مغنيسيوم ستياريت ،</p><p>ومواد مغلفة معويا &nbsp;(إيودراجت &nbsp;&nbsp;L30D-55 ، تراي إيثايل سيتريت، تيتينيوم دايوكسايد و تالك نقي).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            كل قرص مغلف تغليف معوي بلون أبيض الى أبيض داكن دائري مع نقش RP على جانب و رقم 7 على الجانب الأخر
تحتوي العبوة على (20) قرص مغلف تغليف معوي من رومافن 25 ملجم أقراص
كل شريط شفاف (PVDC-PVC/Alu) يحتوي على  10 أقراص

        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>اسم</strong><strong> </strong><strong>وعنوان</strong><strong> </strong><strong>مالك</strong><strong> </strong><strong>رخصة</strong><strong> </strong><strong>التسويق</strong><strong> </strong><strong>والمصنع</strong></p><p>شركة المنتجات الطبية والتجميلية المحدودة (الرياض فارما)</p><p>ص.ب. 442 الرياض 11411</p><p>فاكس: 966112650505+</p><p>البريد الإلكتروني:</p><p>contact@riyadhpharma.com</p><p>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</p><p>المملكة العربية السعودية</p><p>قسم التسويق</p><p>الرياض</p><p>تلفون 966112650111+</p><p>البريد الإلكتروني:</p><p>marketing@riyadhpharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ   (5/2018) 


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rumafen tablets 25mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Diclofenac sodium 25mg
For a full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Enteric Coated tablet
White to off white , enteric coated , biconvex, circular tablets with RP engraved on one side and 7 on the other side

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS</strong></p><p><strong>Cardiovascular Thrombotic Events</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke ,which can be fatal. This risk may occur early in treatment and may increase with duration of use</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diclofenac Sodium delayed-release tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery</p><p><strong>Gastrointestinal Bleeding, Ulceration and perforation</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration and perforation of the stomch or intestines, which can be fatal.These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>Adults and Elderly</strong></p><p>Relief of all grades of pain and inflammation in a wide range of conditions, including</p><p>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; arthritic conditions: rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout</p><p>ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acute musculo-skeletal disorders such as periarthritis (for example frozen shoulder), tendinitis, tenosynovitis, bursitis</p><p>iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;other painful conditions resulting from trauma, including fracture, low back pain, sprains, strains, dislocations, orthopaedic, dental and other minor surgery</p><p>&nbsp;</p><p><strong>Children</strong></p><p>Children aged 1-12 years: for treatment of juvenile chronic arthritis</p><p>Children aged 9 years and above: for short term treatment of fever related to infections of the ear, nose or throat (ENT), e.g. pharyngotonsillitis, otitis media. As monotherapy or as adjunct therapy with morphine or other opiates (due to its opiate-sparing effect) for the relief of acute post-operative pain</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4 Special warnings and precautions for use</p><p>For oral administration</p><p><strong>Adults</strong>: 75-150mg daily in two or three divided doses</p><p>The recommended maximum daily dose of &nbsp;Rumafen &nbsp;is 150mg</p><p>&nbsp;</p><p><strong>Special populations </strong></p><p><strong>Elderly </strong></p><p>Although the pharmacokinetics of Rumafen are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in such patients who generally are more prone to adverse reactions. In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight (see also precautions) and the patient should be monitored for GI bleeding during NSAID therapy</p><p>&nbsp;</p><p><strong>Renal impairment </strong></p><p>Diclofenac is contraindicated in patients with severe renal impairment (see section 4.3). No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering diclofenac to patients with mild to moderate renal impairment (see section 4.3 and 4.4)</p><p>&nbsp;</p><p><strong>Hepatic impairment </strong></p><p>Diclofenac is contraindicated in patients with severe hepatic impairment (see section 4.3). No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering diclofenac to patients with mild to moderate hepatic impairment (see section 4.3 and 4.4).</p><p>&nbsp;</p><p><strong><em><u>Paediatric population</u></em></strong></p><p>For treatment of Juvenile chronic arthritis the following dosage should be given: Children (aged 1-12 years): 1-3 mg/kg per day in divided doses. For the short term treatment of fever related to infections of the ear, nose or throat (ENT) and post-operative pain the following dosage should be given</p><p>Children aged 9 years (min. 35 kg BW) or over and adolescents should be given up to 2 mg/kg body weight per day in 3 divided doses, depending on the severity of the disorder</p><p><u>Method of administration</u></p><p>For oral administration</p><p>To be taken whole with liquid, preferably with or after food</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the active substance or any of the excipients
•	Active, or gastric or intestinal ulcer, bleeding or perforation
•	History of gastrointestinal bleeding or perforation, relating to previous NSAID therapy
•	Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding)
•	Last trimester of pregnancy (see section 4.6 Pregnancy and lactation)
•	Hepatic failure
•	Renal failure
•	Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease
•	Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General &nbsp;</strong></p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 Posology and method of administration and GI and cardiovascular risks below</p><p>&nbsp;</p><p>The concomitant use of Rumafen with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5 Interactions with other medicaments and other forms of interaction</p><p>&nbsp;</p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight (see section 4.2 Posology and Method of administration</p><p>&nbsp;</p><p>As with other nonsteroidal anti-inflammatory drugs including diclofenac, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur without earlier exposure to the drug (see section 4.8 Undesirable effects</p><p>&nbsp;</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of the infection due to its pharmacodynamic properties</p><p>&nbsp;</p><p>This medicine contains lactose and therefore are not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency or glucose-galactose malabsorption</p><p>&nbsp;</p><p><strong>Gastrointestinal effects</strong></p><p>Gastrointestinal bleeding (haematemesis, melaena) ulceration or perforation which can be fatal has been reported with all NSAIDs including diclofenac and may occur at any time during treatment, with or without warning symptoms or a previous history of serious GI events. They generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the drug should be withdrawn</p><p>&nbsp;</p><p>As will all NSAIDs, including diclofenac close medical surveillance is imperative and particular caution should be excised when prescribing diclofenac in patients with symptoms indicative of gastrointestinal disorders, or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8 Undesirable effects). The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses including diclofenac, and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation</p><p>&nbsp;</p><p>The elderly have increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2 Posology and method of administration</p><p>&nbsp;</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose</p><p>&nbsp;</p><p>Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low dose acetylsalicylic acid (ASA/aspirin or medicinal products likely to increase gastrointestinal risk. (See section 4.5 Interactions with other medicaments and other forms of interaction</p><p>&nbsp;</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding</p><p>&nbsp;</p><p>Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants such as warfarin, selective serotoninreuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5 Interaction with other medicaments and other forms of interaction)</p><p>&nbsp;</p><p>Close medical surveillance and caution should be exercised in patients with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8 Undesirable effects</p><p>&nbsp;</p><p><strong>Hepatic Impairments</strong></p><p>Close medical surveillance is required when prescribing Rumafen to patients with impairment of hepatic function as their condition may be exacerbated</p><p>&nbsp;</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with Diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure</p><p>&nbsp;</p><p>If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia, rash), Rumafen should be discontinued</p><p>&nbsp;</p><p>Hepatitis may occur with diclofenac without prodromal symptoms</p><p>&nbsp;</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack</p><p>&nbsp;</p><p><strong>Renal Impairments</strong></p><p>As fluid retention and oedema have been reported in association with NSAIDs therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications). Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases. Discontinuation therapy is usually followed by recovery to the pre-treatment state</p><p>&nbsp;</p><p><strong>Skin effects</strong></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including Rumafen (see section 4.8 Undesirable effects). Patients appear to be at the highest risk of these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Rumafen should be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity</p><p>&nbsp;</p><p><strong>SLE and mixed connective tissue disease</strong></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8 Undesirable effects</p><p>&nbsp;</p><p><strong>Cardiovascular and cerebrovascular effects</strong></p><p>Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful consideration. As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The pateint&rsquo;s need for symptomatic relief and response to therapy should be re-evaluated periodically</p><p>&nbsp;</p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy including diclofenac</p><p>&nbsp;</p><p>Clinical trial and epidemiological data consistently point towards increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with diclofenac after careful consideration</p><p>&nbsp;</p><p><strong>Haematological effects</strong></p><p>During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of the blood count is recommended</p><p>&nbsp;</p><p>Rumafen may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5 Interaction with other medicaments and other forms of interactions). Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should be carefully monitored</p><p>&nbsp;</p><p><strong>Pre-existing asthma</strong></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&rsquo;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria</p><p>&nbsp;</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of bronchial asthma</p><p>&nbsp;</p><p><strong>Female fertility</strong></p><p>The use of Rumafen may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Rumafen should be considered (see section 4.6 Pregnancy and Lactation)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with diclofenac gastro-resistant tablets and/or other pharmaceutical forms of diclofenac</p><p><strong>Lithium:</strong> If used concomitantly, Rumafen may increase plasma concentrations of lithium Monitoring of the serum lithium level is recommended</p><p><strong>Digoxin:</strong> If used concomitantly, Rumafen may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended</p><p><strong>Diuretics and antihypertensive agents:</strong> Like other NSAIDs, concomitant use of Rumafen with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis. Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity</p><p><strong>Drugs known to cause hyperkalemia:</strong> Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4 Special warnings and precautions for use)</p><p><strong>Anticoagulants and anti-platelet agents:</strong> Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4 Special warnings and precautions for use). Although clinical investigations do not appear to indicate that diclofenac has an influence on the effect of anticoagulants, there are reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulant concomitantly (see section 4.4 Special warnings and precautions for use). Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required. As with other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet aggregation</p><p><strong>Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids:</strong> Co-administration of diclofenac with other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more NSAIDs (see section 4.4 Special warnings and precautions for use</p><p><strong>Selective serotonin reuptake inhibitors (SSRIs):</strong> Concomitant administration of SSRI&rsquo;s may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and precautions for use</p><p><strong>Antidiabetics:</strong> Clinical studies have shown that Rumafen can be given together with oral antidiabetic agents without influencing their clinical effect. However there have been isolated reports of hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy</p><p><strong>Methotrexate:</strong> Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increase. Cases of serious toxicity have been reported when methotrexate and NSAIDs including diclofenac are given within 24 hours of each other. This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID <strong>Ciclosporin:</strong> Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin</p><p><strong>Tacrolimus:</strong> Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus. This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor</p><p><strong>Quinolone antibacterials:</strong> Convulsions may occur due to an interaction between quinolones and NSAIDs. This may occur in patients with or without a previous history of epilepsy or convulsions. Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID <strong>Phenytoin:</strong> When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin</p><p><strong>Colestipol and cholestyramine:</strong> These agents can induce a delay or decrease in absorption of diclofenac</p><p>Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol/ cholestyramine</p><p><strong>Cardiac glycosides:</strong> Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels</p><p><strong>Mifepristone:</strong> NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone</p><p><strong>Potent CYP2C9 inhibitors:</strong> Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy </strong></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and or cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1% up to approximately 1.5%</p><p>&nbsp;</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has shown to result in increased pre-and post-implantation loss and embryo-foetal lethality</p><p>&nbsp;</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during organogenetic period. If Rumafen is used by a woman attempting to conceive, or during the 1st trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible</p><p>&nbsp;</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to</p><p>o&nbsp;&nbsp; cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension</p><p>o&nbsp;&nbsp; renal dysfunction, which may progress to renal failure with oligo-hydroamniosis</p><p>The mother and the neonate, at the end of the pregnancy, to</p><p>o&nbsp;&nbsp; possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses</p><p>o&nbsp;&nbsp; inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>Consequently, Rumafen is contra-indicated during the third trimester of pregnancy</p><p><strong>Breast-feeding</strong></p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore, diclofenac should not be administered during breast feeding in order to avoid undesirable effects in the infant (see section 5.2 Pharmacokinetic properties)</p><p>&nbsp;</p><p><strong>Female fertility</strong></p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac should be considered. See also section 4.4 Special warnings and precautions for use, regarding female fertility</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, vertigo, somnolence, central nervous system disturbances, drowsiness or fatigue while taking NSAIDs should refrain from driving or operating machinery</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following</p><p>convention: very common: (&gt;1/10); common (&ge; 1/100, &lt;1/10); uncommon (&ge; 1/1,000, &lt;1/100); rare</p><p>(&ge;1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be estimated from available data</p><p>&nbsp;</p><p>The following undesirable effects include those reported with other short-term or long-term use</p><p><strong>Table 1</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leucopoenia, anaemia (including haemolytic and aplastic anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p><p>Angioneurotic oedema (including face oedema).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>Unknown</p></td><td style="vertical-align:top"><p>Headache, dizziness.</p><p>Somnolence, tiredness.</p><p>Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p><p>Confusion, hallucinations, disturbances of sensation, malaise.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p><p>Unknown</p></td><td style="vertical-align:top"><p>Visual disturbance, vision blurred, diplopia.</p><p>Optic neuritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Very rare</p></td><td style="vertical-align:top"><p>Vertigo.</p><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon*</p></td><td style="vertical-align:top"><p>Myocardial infarction, cardiac failure, palpitations, chest pain.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension, hypotension, vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Asthma (including dyspnoea).</p><p>Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Unknown</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia.</p><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly).</p><p>Colitis (including haemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis. Ischaemic colitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Transaminases increased.</p><p>Hepatitis, jaundice, liver disorder.</p><p>Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Rash.</p><p>Urticaria.</p><p>Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>impotence.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr></tbody></table><p>&nbsp;</p><p>* The frequency reflects data from long-term treatment with a high dose (150 mg/day). Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high doses (150 mg daily) and in long term treatment (see sections 4.3 and 4.4 for Contraindications and Special warnings and special precautions for use)</p><p>&nbsp;</p><p>To report any side effects</p><p>National Pharmacovigilance and Drug Safety Center (NPC</p><p>o Fax: +966-11-205-7662</p><p>o To call the executive management of vigilance and crisis management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340</p><p>o Toll-free: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms </strong></p><p>There is no typical clinical picture resulting from diclofenac over dosage. Over dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, diarrhoea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting or convulsions. In the case of significant poisoning acute renal failure and liver damage are possible</p><p>&nbsp;</p><p><strong>Therapeutic measures</strong></p><p>Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression</p><p>&nbsp;</p><p>Special measures such as forced diuresis, dialysis or haemo-perfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to high protein binding and extensive metabolism</p><p>&nbsp;</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life threatening overdose</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group</p><p>Non-steroidal anti-inflammatory drugs (NSAlDs</p><p>&nbsp;</p><p>Mechanism of action Rumafen is a non-steroidal agent with marked analgesic/anti inflammatory properties. It is an inhibitor of prostaglandin synthetase, (cyclo-oxygenase</p><p>Diclofenac sodium in vitro does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in human beings</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Absorption is complete but onset is delayed until passage through the stomach, which may be affected by food which delays stomach emptying. The mean peak plasma diclofenac concentration reached at about 2 hours (50mg dose produces 1.48 &plusmn; 0.65&micro;g/ml (1.5&micro;g/ml &equiv; 5&micro;mol/l))</p><p>&nbsp;</p><p><strong>Bioavailability</strong></p><p>About half of the administered diclofenac is metabolised during its first passage through the liver (&quot;first-pass&quot; effect), the area under the concentrations curve (AUC) following oral administration is about half that following an equivalent parenteral dose</p><p>&nbsp;</p><p>Pharmacokinetic behaviour does not change on repeated administration. Accumulation does not occur, provided the recommended dosage intervals are observed</p><p>&nbsp;</p><p><strong>Distribution</strong></p><p>The active substance is 99.7% protein bound, mainly to albumin (99.4%</p><p>&nbsp;</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4 hours after the peak plasma values have been attained. The apparent half-life for elimination from the synovial fluid is 3-6 hours. Two hours after reaching the peak plasma values, concentrations of the active substance are already higher in the synovial fluid than they are in the plasma and remain higher for up to 12 hours</p><p>&nbsp;</p><p>Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose (see section 4.6 Pregnancy and lactation)</p><p>&nbsp;</p><p><strong>Metabolism</strong></p><p>Biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites, most of which are converted to glucuronide conjugates. Two phenolic metabolites are biologically active, but to a much lesser extent than diclofenac</p><p>&nbsp;</p><p><strong>Elimination</strong></p><p>The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 mL/min (mean value &plusmn; SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites, including the two active ones, also have short plasma half-lives of 1-3 hours</p><p>&nbsp;</p><p>About 60% of the administered dose is excreted in the urine in the form of the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the faeces</p><p>&nbsp;</p><p><strong>Characteristics in patients </strong></p><p><em>Elderly</em>: No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or excretion have been observed, other than the finding that in five elderly patients, a 15 minute iv infusion resulted in 50% higher plasma concentrations than expected with young healthy subjects</p><p><em>Patients with renal impairment</em>: In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a creatinine clearance of&gt; 10ml/min the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects. However, the metabolites are ultimately cleared through the bile</p><p>&nbsp;</p><p><em>Patients with hepatic disease</em>: In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Core</em></strong></p><p>Microcrystalline cellulose PH101</p><p>Lactose 100 MESH</p><p>Maize starch</p><p>Povidone K30</p><p>Magnesium stearate</p><p>&nbsp;</p><p><strong><em>Enteric coat</em></strong></p><p>Eudragit L30D-55 (Methacrylic acid copolymer</p><p>Triethyl citrate</p><p>Titanium dioxide</p><p>Purified talc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Three years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 &deg;C</p><p>Store in original package in order to protect from light</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10s Blister of transparent PVC-PVDC film / Aluminum foil</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder and Manufacturer
Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O.Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation holder
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>